華力創通(300045.SZ):目前公司的北斗+5G產品尚處於研製階段
格隆匯5月18日丨有投資者在投資者互動平台向華力創通(300045.SZ)提問,“公司的北斗+5G項目到可以商用的地步了嗎?未來公司的北斗終端產品有考慮與華為和小米等國內頭部企業商業合作嗎?公司的衞星產品目前在機載和車載領域已經開始商用了嗎?”
華力創通回覆稱,目前公司的北斗+5G 產品尚處於研製階段;公司非常樂於和優秀的企業開展合作併為此而積極努力;公司已經研製了適用於機載和車載領域的相應產品,並且積極的進行對接和試用。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.